An index of 5-HT synthesis changes during early antidepressant treatment: α-[11C]methyl-l-tryptophan PET study

The antidepressant selective serotonin transporter inhibitors (SSRIs) are clinically active after a delay of several weeks. Indeed, the rapid increase of serotonin (5-HT) caused by SSRIs, stimulates the 5-HT(1A) autoreceptors, which exert a negative feedback on the 5-HT neurotransmission. Only when autoreceptors are desensitized, can SSRIs exert their therapeutic activity. The 5-HT(1A) receptor antagonist pindolol has been used to accelerate the clinical effects of antidepressant by preventing the negative feedback. Using the alpha-[(11)C]methyl-L-tryptophan/positron emission tomography (PET), the goal of the present double-blind, randomized study was to compare the changes in alpha-[(11)C]methyl-L-tryptophan trapping, an index of serotonin synthesis, in patients suffering from unipolar depression treated with the SSRI citalopram (20 mg/day) plus placebo versus patients treated with citalopram plus pindol (7.5 mg/day). PET and Hamilton depression rating scale (HDRS-17) were performed at baseline, and after 10 and 24 days of antidepressant treatment. Results show that the combination citalopram plus pindol, compared to citalopram alone shows a more rapid and greater increase of an index of 5-HT synthesis in prefrontal cortex (BA 9). This research is the first human PET study demonstrating that, after 24 days, the combination SSRIs plus pindolol produces a greater increase of the metabolism of serotonin in the prefrontal cortex, an area associated to depressive symptoms.

[1]  P. Cowen,et al.  Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low. , 2001, The American journal of psychiatry.

[2]  F. Lejeune,et al.  Pindolol excites dopaminergic and adrenergic neurons, and inhibits serotonergic neurons, by activation of 5‐HT1A receptors , 2000, The European journal of neuroscience.

[3]  David A Lewis,et al.  Neural and behavioral substrates of mood and mood regulation , 2002, Biological Psychiatry.

[4]  Mirko Diksic,et al.  Image generation of serotonin synthesis rates using α-methyltryptophan and PET , 1998 .

[5]  M. Fava,et al.  Major Depressive Disorder , 2000, Neuron.

[6]  C. Montigny,et al.  Selective Activation of Postsynaptic 5-HT1A Receptors Induces Rapid Antidepressant Response , 1997, Neuropsychopharmacology.

[7]  H. Okazawa,et al.  Validation of a Less-Invasive Method for Measurement of Serotonin Synthesis Rate with α-[11C]Methyl-Tryptophan , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  Joel Paris,et al.  Brain Regional α-[11C]Methyl-l-Tryptophan Trapping in Impulsive Subjects With Borderline Personality Disorder , 2001 .

[9]  V. Pérez,et al.  Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. , 1994, Archives of general psychiatry.

[10]  M. Diksic,et al.  Brain Net Unidirectional Uptake of α-[14C]Methyl-L-Tryptophan (α-MTrp) and Its Correlation with Regional Serotonin Synthesis, Tryptophan Incorporation into Proteins, and Permeability Surface Area Products of Tryptophan and α-MTrp , 2000, Neurochemical Research.

[11]  C. Ribelayga,et al.  Generation of the Melatonin Endocrine Message in Mammals: A Review of the Complex Regulation of Melatonin Synthesis by Norepinephrine, Peptides, and Other Pineal Transmitters , 2003, Pharmacological Reviews.

[12]  H. Meltzer,et al.  Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex , 2006, Psychopharmacology.

[13]  Detection of Hepatocellular Carcinoma: Combined T2-Weighted and Dynamic Gadolinium-Enhanced MRI Versus Combined CT During Arterial Portography and CT Hepatic Arteriography , 2001, Journal of computer assisted tomography.

[14]  M. Tome,et al.  Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency , 1997, International clinical psychopharmacology.

[15]  D. Puigdemont,et al.  A double-blind, randomized, placebo-controlled trial of Pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors , 1999 .

[16]  P. Jerabek,et al.  Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response , 2000, Biological Psychiatry.

[17]  Yasuyuki Sakai,et al.  Cortical trapping of α-[11C]methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males , 2006, NeuroImage.

[18]  H L Miller,et al.  Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. , 1997, Archives of general psychiatry.

[19]  E. Domenici,et al.  Chronic Social Stress Inhibits Cell Proliferation in the Adult Medial Prefrontal Cortex: Hemispheric Asymmetry and Reversal by Fluoxetine Treatment , 2007, Neuropsychopharmacology.

[20]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[21]  G. Debonnel,et al.  Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex , 2007, The Journal of Neuroscience.

[22]  M. Nishikawa,et al.  Increasing blood oxygen increases an index of 5-HT synthesis in human brain as measured using α-[11C]methyl-l-tryptophan and positron emission tomography , 2005, Neurochemistry International.

[23]  G. Aghajanian,et al.  Serotonin-Containing Neurons in Brain: Depression of Firing by Monoamine Oxidase Inhibitors , 1970, Science.

[24]  Monte S. Buchsbaum,et al.  Effect of sertraline on regional metabolic rate in patients with affective disorder , 1997, Biological Psychiatry.

[25]  P. Fox,et al.  Cingulate function in depression: a potential predictor of treatment response , 1997, Neuroreport.

[26]  P. Celada,et al.  How does pindolol improve antidepressant action? , 2001, Trends in pharmacological sciences.

[27]  V. Arango,et al.  A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. , 2000, Archives of general psychiatry.

[28]  G Blomqvist,et al.  On the Construction of Functional Maps in Positron Emission Tomography , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[30]  J. Mazziotta,et al.  Reduction of prefrontal cortex glucose metabolism common to three types of depression. , 1989, Archives of general psychiatry.

[31]  W. Drevets.  Neuroimaging studies of mood disorders , 2000, Biological Psychiatry.

[32]  H. Mayberg.  Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. , 2003, British medical bulletin.

[33]  M Diksic,et al.  Differences between males and females in rates of serotonin synthesis in human brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Pedro Rosa-Neto,et al.  Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. , 2004, Archives of general psychiatry.

[35]  Mirko Diksic,et al.  Study of the brain serotonergic system with labeled α‐methyl‐l‐tryptophan , 2001 .

[36]  R. Hen,et al.  Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.

[37]  L. Callado,et al.  Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials. , 2004, Journal of affective disorders.

[38]  E. Smeraldi,et al.  Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study. , 1998, Journal of clinical psychopharmacology.

[39]  S. Maier,et al.  Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus , 2005, Nature Neuroscience.

[40]  Alicia Izquierdo,et al.  Brief Uncontrollable Stress Causes Dendritic Retraction in Infralimbic Cortex and Resistance to Fear Extinction in Mice , 2006, The Journal of Neuroscience.

[41]  M. Weissman,et al.  Ethnic and sex differences in suicide rates relative to major depression in the United States. , 2001, The American journal of psychiatry.

[42]  O. Muzik,et al.  α[C-11]Methyl-l-Tryptophan PET Maps Brain Serotonin Synthesis and Kynurenine Pathway Metabolism , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[43]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[44]  Osama Mawlawi,et al.  Differential Occupancy of Somatodendritic and Postsynaptic 5HT1A Receptors by Pindolol: A Dose-Occupancy Study with [11C]WAY 100635 and Positron Emission Tomography in Humans , 2001, Neuropsychopharmacology.

[45]  H. Okazawa,et al.  Effects of Acute and Chronic Administration of the Serotonin1A Agonist Buspirone on Serotonin Synthesis in the Rat Brain , 1999, Journal of neurochemistry.

[46]  J. Mazziotta,et al.  MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.

[47]  S. Houle,et al.  Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. , 2001, The American journal of psychiatry.

[48]  R. Salomon,et al.  Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action , 1999, Biological Psychiatry.

[49]  R. Dolan,et al.  Changes in regional cerebral blood flow on recovery from depression , 1995, Psychological Medicine.

[50]  C. Montigny,et al.  Serotonin and Drug-Induced Therapeutic Responses in Major Depression, Obsessive–Compulsive and Panic Disorders , 1999, Neuropsychopharmacology.

[51]  S. Alborzian,et al.  Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine , 1999, Psychiatry Research: Neuroimaging.

[52]  A. Anand,et al.  Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. , 1997, The American journal of psychiatry.

[53]  F. Artigas,et al.  Role of 5‐HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies , 1996, Fundamental & clinical pharmacology.

[54]  M. Raichle,et al.  Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism , 2002, European Neuropsychopharmacology.

[55]  L. Parsons,et al.  Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. , 1999, The American journal of psychiatry.

[56]  F. Artigas,et al.  Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex. , 2005, European journal of pharmacology.

[57]  R. Duman,et al.  Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat , 2004, Biological Psychiatry.

[58]  C. Benkelfat,et al.  Depressive relapse following acute tryptophan depletion in patients with major depressive disorder , 2000, Journal of psychopharmacology.

[59]  C. Montigny,et al.  Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors , 1985, Neuroscience.

[60]  D. Collins,et al.  Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space , 1994, Journal of computer assisted tomography.

[61]  M. Torrens.  Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .